china pharmaceutical business market forecast and investment strategy report, 2013 2017

2011紧固件制造行

业

前瞻服务热线： 800-8306390 800-8306395 400-0687188 传真： 0755-82940718 [email protected]

China Pharmaceutical Business Market Forecast and Investment

Strategy Report, 2013-2017No comprehensive trend forecast, no gain.

(Help you to discover the unsatisfied market need of Pharmaceutical Business, and explicit the development

trend and prospect.)

Preface

It is an oversupply economic era and key for corporations to success is that whether they are able to capture

the demand before the demand takes shape. The outstanding corporations would prefer to spend great efforts

in seeking the current demand, potential need and new requirement of the industry.

Competition of nonwoven industry is more and more fierce. In the meantime, merger and capital operation

among large pharmaceutical corporations are ever frequent. And the outstanding pharmaceutical corporations

in China are placing more importance on the research of the industry market, especially the depth research of

industry development environment and customers. Accordingly, many splendid domestic corporations are

springing up and become leaders in pharmaceutical business gradually!

Basing on the market data of pharmaceutical business

http://en.qianzhan.com/report/detail/d5364bdb17284a6b.html , which tracked

and collected by Forward in long-term, and applying the international scientific analysis model, this report

provides you an overall analysis system in the height of the whole industry comprehensively and accurately.

This report mainly analysis the following aspects of Pharmaceutical Business: the development policy

environment and demanding environment of Pharmaceutical Business; development status and prospect of

Pharmaceutical Business; competition and the development of competitors; development status of

Pharmaceutical wholesaling market; development of Pharmaceutical logistics market; development of the

terminal of Pharmaceutical Business; and development of Pharmaceutical Business in major cities.

Meanwhile, the comprehensive and detailed data about nonwoven industry in current 5 years is contained. In

this way, it will help you to maintain the market trend and industry development comprehensively and

accurately.

The most significant features of this report are perceptiveness and timeliness. It gives a prudent analysis and

forecast of pharmaceutical business according to the industry development track and Forward ’s years of

practical experience. In conclusion, it is a significant report to learn about the latest development trend, grab

market opportunities, and make correct marketing decision and explicit corporations’ development trend for

all Pharmaceutical wholesalers, retailers, logistics corporations and investors. Besides, it is the first

heavyweight report to give a comprehensive and systematic analysis about the significant Pharmaceutical

corporations.

This report is useful for pharmaceutical wholesalers, retailers, logistics corporations and investors for the

following reasons: it will help them to accurately know the latest development trend and timely discover the

market gaps, opportunities, growth points and profit points of industrial textile industry; it will assist them to

grasp the unmet market demand and development trend prospectively, form the sustainable advantages, avoid

the investment risks effectively, consolidate or expand relevant strategic target markets more efficiently, and

firmly grasp the competition initiative.

Here, we would like to express our sincere gratitude to China Association of Pharmaceutical Commerce,

State Information Center, Bureau of Statistics of China, General Administration of Customs, International

Information Research Institute, Chinese Academy of International Trade and Economic Cooperation,

Tsinghua University Library, Development Research Center of the State Council, for their great support when

we conduct this report!

http://en.qianzhan.com/report/detail/d5364bdb17284a6b.html

Notice: All the market data, especially corporations' ranking data in the report, only for business reference.

Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility

for any consequences!

Special Notes: Neglecting the subtle signals of dramatically changing external environment, and untimely

update strategies along with the changing environment will lead to the loss of competition advantages. The

successful corporations will keep a scientific analysis upon the external environment before making their

significant operational strategies!

Forward Business Intelligence sincerely wishes every ambitious corporation can make a significant

operational strategy, effectively avoid the industry risks and gain the continuous success!

Forward Business Intelligence Co., Ltd. Industry Research Center

Research Team of Pharmaceutical Business

CONTENTS

Chapter I：Development Background of Pharmaceutical Business

1.1 Researching Methods and Data Sources

1.1.1 Researching Methods

1.1.2 Data Sources

1.2 Definition and Classification of Pharmaceutical Business

1.2.1 Definition of Pharmaceutical Business

1.2.2 Operation Characteristics of Pharmaceutical Business

1.2.3 Types of Pharmaceutical Corporations

1.3 Entry Barriers of Pharmaceutical Business

1.3.1 Barrier of Professional Accreditation

1.3.2 Barrier of Operation Qualification

1.3.3 Barrier of Corporation Scale

1.3.4 Barrier of Brand and Reputation

1.3.5 Barrier of Asset and Strength

1.3.6 Barrier of Marketization

1.3.7 Barrier of Policy

1.4 Policy Environment of Pharmaceutical Business

1.4.1 Supervision Department of Pharmaceutical Business

1.4.2 Management System of Pharmaceutical Business

1.4.3 Development Planning of Pharmaceutical Business

1.5 Economic Environment of Pharmaceutical Business

1.5.1 China GDP Growth

1.5.2 Influence of GDP to Pharmaceutical Business

1.6 Demand Environment of Pharmaceutical Business

1.6.1 Payment Capability of Residents

1.6.2 Aging and Pharmaceutical Business

1.6.3 Urbanization and Pharmaceutical Business

Chapter II：Development Status and Prospect of Pharmaceutical Business

2.1 Status and Management Model of Pharmaceutical Supply Chain

2.1.1 Definition of Pharmaceutical Supply Chain

2.1.2 Construction of Pharmaceutical Supply Chain

2.1.3 Development Progress of Pharmaceutical Supply Chain

2.1.4 Management Model of Pharmaceutical Supply Chain

(1) Hospital-orient Management Model of Pharmaceutical Supply Chain

(2) Supplier-orient Management Model of Pharmaceutical Supply Chain

(3) Third-party-Drug-Logistics-orient Management Model of Pharmaceutical Supply Chain

(4) Compare of Three Kinds of Management Models of Pharmaceutical Supply Chain

2.2 Business Model and Marketing Strategy of Pharmaceutical Business

2.2.1 Business Models of Pharmaceutical Business

(1) Business Model of Retailing Only

(2) Business Model of Promotion

(3) Business Model of Wholesaling

(4) Business Model of Agency Service

(5) Business Model of Distribution

(6) Innovation of Pharmaceutical Business Models

2.2.2 Channels of Pharmaceutical Business

2.2.3 Selection of Marketing Channels of Pharmaceutical Business

(1) Influent Factors to Select the Marketing Channel

(2) Corporation’s Sales Team plus Distributors

(3) Sole Agency

(4) Corporation’s Sales Team plus Regional Dealers

(5) Multi-agency Model

2.3 Development Model and Profit of Pharmaceutical Business

2.3.1 Amount of Pharmaceutical Corporations

(1) Corporation Amount and Size

(2) Regional Distribution of the Corporations

2.3.2 Market Size of Pharmaceutical Business

(1) Total Sales Volume

(2) Regional Sales Distribution

2.3.3 Profit of Pharmaceutical Business

(1) Traditional Profit Model of Pharmaceutical Business

(2) New Profit Model of Pharmaceutical Business

(3) Changing of the Profit Level of Pharmaceutical Business

(4) Profit Factors of Pharmaceutical Business

2.4 Products Market Size of Pharmaceutical Business

2.4.1 Overview of 7 Major Medicines Market

(1) Scale of 7 Major Medicines Market

(2) Structure of 7 Major Medicines Market

2.4.2 Analysis of Drug Market

(1) Sales of Drugs

(2) Pharmacy Scale of the Hospitals

(3) Imports and Exports of Drugs

2.4.3 Analysis of Chinese Patent Medicine Market

(1) Sales of Chinese Patent Medicine

a. Change of Sales Amount

b. Change of Sales Proportion

c. Regional Distribution

(2) Production of Chinese Patent Medicine

(3) Imports and Exports of Chinese Patent Medicine

2.4.4 Analysis of Chinese Herbal Medicine Market

(1) Sales of Chinese Herbal Medicine




(2) Imports and Exports of Chinese Herbal Medicine

(3) Circulation Status of Chinese Herbal Medicine

2.4.5 Analysis of Medical Apparatus and Instruments Market

(1) Sales of Medical Apparatus and Instruments




(2) Imports and Exports of Medical Apparatus and Instruments

a. Imports Status

b. Exports Status

(3) Major Medical Apparatus and Instruments

2.4.6 Analysis of Chemical Reagent Market

(1) Sales of Chemical Reagent



(2) Major Chemical Reagent Products

2.4.7 Analysis of Glassware Instrument Market

2.4.8 Market of other Products

2.5 Prospect Forecast of the Development of Pharmaceutical Business

2.5.1 Driving Factors to the Development of Pharmaceutical Business

2.5.2 Limited Factors to the Development of Pharmaceutical Business

2.5.3 Development Prospect of Pharmaceutical Business

Chapter III：Competition of Significant Pharmaceutical Corporations

3.1 Competitive Structure of Pharmaceutical Corporations

3.1.1 Scale and Structure of Pharmaceutical Corporations

3.1.2 Concentration Ratio of Pharmaceutical Corporations

(1) Upgrading Bottom Line of Top 100 Corporations

(2) Market Concentration Ratio of Top 3 Pharmaceutical Corporations

(3) Concentration Ratio Forecast of Pharmaceutical Business

3.2 Financing Strategy of Pharmaceutical Corporations

3.2.1 Financing Model of Pharmaceutical Corporations

3.2.2 Financing Channel of Public Pharmaceutical Company

3.2.3 Financing Cases of Public Pharmaceutical Company

3.2.4 Financing Strategy of Public Pharmaceutical Company

3.3 Analysis of Major Pharmaceutical Corporations

3.3.1 Analysis of Sinopharm Group Co., Ltd.

(1) Development Briefing of the Company

(2) Major Business and Products of the Company

(3) Major Customers and Suppliers of the Company

(4) Operation Status of the Company

a. Major Economic Indexes

b. Profitability of the Company

c. Operation Capability of the Company

d. Debt-paying Capability of the Company

e. Development Capability of the Company

(5) Operation Advantages and Disadvantages of the Company

(6) Logistics System Construction of the Company

(7) Investment and Development Trend of the Company

(8) Subsidiary of Sinopharm Group Co., Ltd.

a. Development Briefing

b. Category of the Retailing Products

c. Operation Status

d. Distribution of Retailing Network

3.3.2 Analysis of China National Accord Medicines Corporation Ltd.

(Analysis items are identical to the first company)

3.3.3 Analysis of China National Medicines Corporation Ltd.


3.3.4 Analysis of Shanghai Pharmaceuticals Holding Co., Ltd.


3.3.5 Analysis of Nanjing Pharmaceutical Co., Ltd.


3.3.6 Analysis of Guangzhou Pharmaceutical Co., Ltd.


3.3.7 Analysis of Anhui Huayuan Pharmaceutical Co., Ltd.


3.3.8 Analysis of Beijing Pharmaceutical CO., LTD.


3.3.9 Analysis of Jointown Pharmaceutical Group Co., Ltd.


3.3.10 Analysis of Tianjin Pharmaceutical Holdings Ltd.


3.3.11 Analysis of Huadong Medicine Co., Ltd.


3.3.12 Analysis of Zhejiang Int'l Group Co., Ltd.


3.3.13 Analysis of Harbin Pharmaceutical Group Co., Ltd.


3.3.14 Analysis of China Meheco Co., Ltd.


3.3.15 Analysis of Shijiazhuang Lerentang Medical Group Co., Ltd.


3.3.16 Analysis of Yunnan Baiyao Group Co., Ltd.


3.3.17 Analysis of Joincare Pharmaceutical Group Industry Co.,Ltd.


3.3.18 Analysis of CHONGQING TONG JUN GE CO., LTD.


3.3.19 Analysis of Chongqing Taiji Industry (Group) Co., Ltd.


3.3.20 Analysis of Shandong Neptunus Group Co., Ltd.


3.3.21 Analysis of Northeast Pharmaceutical Group Co., Ltd.


3.3.22 Analysis of Hebei Dongsheg Yinghua Pharmaceutical Co., Ltd.


3.3.23 Analysis of TASLY PHARMACEUTICAL GROUP CO., LTD.


3.3.24 Analysis of Beijing Tongrentang Co.,Ltd.


3.3.25 Analysis of Shandong Realcan Pharmaceutical Co., Ltd.


3.3.26 Analysis of Cachet Pharmaceutical Co., Ltd.


3.3.27 Analysis of China Nepstar Chain Drugstore Ltd.


3.3.28 Analysis of Lao Bai Xing Big Drugstore Chain Co., Ltd.


3.3.29 Analysis of Guangdong DA SHEN LIN Chain Drugstore Ltd.


Chapter IV：Status and Prospect of Pharmaceutical Wholesaling Market

4.1 Operation Status of Foreign Pharmaceutical Wholesales

4.1.1 Functions of Pharmaceutical Wholesalers

4.1.2 Analysis of Pharmaceutical Wholesalers in America

(1) Pharmaceutical Supply Chain in America

(2) Operation Environment of Pharmaceutical Wholesalers in America

(3) Operation Characteristics of Pharmaceutical Wholesalers in America

(4) Analysis of McKesson

4.1.3 Analysis of Pharmaceutical Wholesalers in Japan

(1) Pharmaceutical Supply Chain in Japan

(2) Operation Environment of Pharmaceutical Wholesalers in Japan

(3) Operation Characteristics of Pharmaceutical Wholesalers in Japan

(4) Analysis of TOHO Medicine Limited

4.2 Status of Pharmaceutical Wholesaling Market in China

4.2.1 Scale of Pharmaceutical Wholesaling Market

(1) Corporation Amount and Size

(2) Sales Scale of the Corporation

4.2.2 Competition Level of Pharmaceutical Wholesaling Market

4.2.3 Competitive Structure of Pharmaceutical Wholesaling Market

(1) Competitive Structure in Different Provinces and Cities

(2) Regional Competitive Structure

4.2.4 Concentration Ratio of Pharmaceutical Wholesalers

4.2.5 Distribution Structure of Competitive Structure

(1) Structure of Total Distribution Amount

(2) Structure of Logistics Cost

4.3 SWOT Analysis of Pharmaceutical Wholesalers in Middle-and-Small Size

4.3.1 Strength of Pharmaceutical Wholesalers in Middle-and-Small Size (S)

4.3.2 Weakness of Pharmaceutical Wholesalers in Middle-and-Small Size (W)

4.3.3 Opportunities of Pharmaceutical Wholesalers in Middle-and-Small Size (O)

4.3.4 Threats of Pharmaceutical Wholesalers in Middle-and-Small Size (T)

4.4 Development Prospects of Pharmaceutical Wholesaling Market

4.4.1 Development Trend of Pharmaceutical Wholesalers

4.4.2 Development Prospects of Pharmaceutical Wholesalers

Chapter V：Status and Business Model of Pharmaceutical Logistics Market

5.1 Status and Prospects of Pharmaceutical Logistics Market in China

5.1.1 Functions and Classification of Pharmaceutical Logistics

(1) Definition of Pharmaceutical Logistics

(2) Functions of Pharmaceutical Logistics

(3) Classification of Pharmaceutical Logistics

5.1.2 Development Status of Pharmaceutical Logistics Market

5.1.3 Operation Characteristics of Pharmaceutical Logistics Market

5.1.4 Logistics Cost of Pharmaceutical Logistics Corporations

5.1.5 Demanding Scale of Pharmaceutical Logistics Market

5.1.6 Competition Status of Pharmaceutical Logistics Market

5.1.7 Development Prospects of Pharmaceutical Logistics Market

5.2 Business Model and Characteristics of International Pharmaceutical Logistics Market

5.2.1 Business Model and Characteristics of Pharmaceutical Logistics Industry in America

5.2.2 Business Model and Characteristics of Pharmaceutical Logistics Industry in Japan

5.2.3 Business Model and Characteristics of Pharmaceutical Logistics Industry in Europe

5.2.4 Development Experience of International Pharmaceutical Logistics Industry

5.3 Cases Study of the Business Models of Pharmaceutical Logistics

5.3.1 Overall Characteristics of the Business Models of Pharmaceutical Logistics

5.3.2 Development Status of the Business Models of Pharmaceutical Logistics

5.3.3 Analysis of Major Business Models of Pharmaceutical Logistics

5.3.4 Advantages and Disadvantages of the Business Models of Pharmaceutical Logistics

5.4 Operation and Characteristics of Pharmaceutical Logistics Segment Markets

5.4.1 Pharmaceutical Logistics Market Majoring in Commercial Distribution

(1) Market Environment of Commercial Distribution Pharmaceutical Logistics

(2) Operation of Commercial Distribution Pharmaceutical Logistics

a. Operation Subjects of Commercial Distribution Pharmaceutical Logistics

b. Operation Presupposition of Commercial Distribution Pharmaceutical Logistics

c. Operation Process of Commercial Distribution Pharmaceutical Logistics

(3) Characteristics of Commercial Distribution Pharmaceutical Logistics

(4) Influencing Factors to Commercial Distribution Pharmaceutical Logistics

(5) Compare of the Same Models at Home and Abroad

a. Commercial Distribution Pharmaceutical Logistics in America

b. Compare of Commercial Distribution Pharmaceutical Logistics between China and America

5.4.2 Pharmaceutical Logistics Market Majoring in Retailing and Chain Operation

(1) Market Environment of Retailing and Chain Operation Pharmaceutical Logistics

(2) Operation of Retailing and Chain Operation Pharmaceutical Logistics

(3) Characteristics of Retailing and Chain Operation Pharmaceutical Logistics

(4) Influencing Factors to Retailing and Chain Operation Pharmaceutical Logistics

(5) Compare of the Same Models at Home and Abroad

5.4.3 Pharmaceutical Logistics Market Majoring in Third-party

(1) Market Environment of Third-party Pharmaceutical Logistics

(2) Operation of Third-party Pharmaceutical Logistics

(3) Characteristics of Third-party Pharmaceutical Logistics

(4) Influencing Factors to Third-party Pharmaceutical Logistics

(5) Innovation of Third-party Pharmaceutical Logistics

Chapter VI：Scale and Development Potentials of Pharmaceutical Terminal Market

6.1 Scale of Pharmaceutical Terminal Market

6.1.1 Total Amount of Pharmaceutical Terminal Market

6.1.2 Distribution of Pharmaceutical Terminal Market

6.2 Development and Pharmacy Demand of Medical Institutions

6.2.1 Development Overview of Medical Institutions

(1) Amount and Scale of Medical Institution

(2) Distribution of Medical Institutions

(3) Operation of Medical Institutions

6.2.2 Development of Major Medical Institutions

(1) Medicine Sales Size in Hospitals

(2) Development of Hospitals

(3) Development of Community Health-care Institutions

(4) Development of Health Centers

6.3 Scale and Development Trend of Retailing Drugstores

6.3.1 Amount and Regional Distribution of Retailing Drugstores

(1) Amount of Retailing Drugstore Corporations

(2) Structure Changing of Retailing Drugstores

6.3.2 Medicine Sales Scale in Retailing Drugstores

6.3.3 Market Concentration Ratio of Retailing Drugstores

6.3.4 Profit Level of Retailing Drugstores

6.3.5 Development Scale of Chain Retailing Drugstores

(1) Growth of Chain Drugstore Corporation Amount

a. Growth of Chain Drugstore Amount

b. Amount and Distribution of China Drugstores

c. Amount and Distribution of China Drugstores in Different Regions

(2) Sales Scale of Chain Retailing Drugstores

6.3.6 Competitive Structure of Chain Retailing Drugstores

(1) Competitive Structure of Chain Drugstore Industry

a. Competitive Structure of Chain Drugstores in China

b. Competitive Structure of Trans-regional Chain Drugstores

c. Competitive Structure of Local Chain Drugstores

(2) Regional Competitive Structure of Chain Drugstore Industry

a. Distribution of Top 100 Corporations

b. Regional Sales Distribution

6.3.7 Top 100 Chain Drugstore Corporations

(1) Sales Revenue Changing of Top 100 Chain Drugstore Corporations

(2) Changing of the Key Corporations of Chain Drugstore Industry

a. Sales Volume/Sub-branch Amount Changing of Top 10 Corporations

b. Sales Volume Changing of Top 10, Top 20, Top 50 and Top 100 Corporations

c. Growing Sales Volume of Top 10 Corporations

(3) Important Shop Changing of Chain Drugstore Industry

a. Amount of Top 10, Top 20, Top 50 and Top 100 Shops

b. Regular Chain Amount of Top 10 Corporations

c. Medical Insurance Drugstore Amount of Top 10 Corporations

(4) Operation Efficiency of Top 100 Chain Drugstore Corporations

a. Unit Price of Top 100 Chain Drugstore Corporations

b. Corporate Member Efficiency of Top 100 Chain Drugstore Corporations

c. Evaluation Efficiency of Top 100 Chain Drugstore Corporations

d. HR Efficiency of Top 100 Chain Drugstore Corporations

6.3.8 Analysis of Top 100 Individual Chain Drugstores

(1) Sales Revenue of Top 100 Individual Chain Drugstores

(2) Evaluation Efficiency of Top 100 Individual Chain Drugstores

(3) HR Efficiency of Top 100 Individual Chain Drugstores

6.3.9 Development Prospects of Retailing Drugstores

6.4 Development Potentials of PharmaceuticalE-commerce Market

6.4.1 Subjects and Development Pattern of PharmaceuticalE-commerce Market

(1) Subjects of PharmaceuticalE-commerce Market

(2) Development Pattern of PharmaceuticalE-commerce

a. Third-party Pharmaceutical E-commerce Platform

b. Pharmaceutical E-commerce Platform Constructed by Pharmaceutical Corporations

c. Pharmaceutical E-commerce Platform Constructed by Pharmaceutical Retailing Corporations

6.4.2 Development Characteristics of Pharmaceutical E-commerce

6.4.3 Development Scale of Pharmaceutical E-commerce

(1) B2B Pharmaceutical E-commerce

(2) B2C Pharmaceutical E-commerce

6.4.4 Typical Cases of Pharmaceutical E-commerce

(1) Golden Elephant Website (www.jxdyf.com)

(2) Drugstore Website (www.yaofang.cn)

(3) Pharmacy Website

(4) Good Pharmacist Website

6.4.5 Development Bottleneck of Pharmaceutical E-commerce

6.4.6 E-commerce Application Prospects of Different Types of Medicine

(1) Over the Counter

(2) Prescription Medicine

(3) Bulk Drug

6.4.7 Development Strategy of Pharmaceutical E-commerce

Chapter Ⅶ：Development Status of Pharmaceutical Business in Major Provinces and Cities

7.1 Status and Terminal of Pharmaceutical Business in Beijing

7.1.1 Development of Pharmaceutical Business in Beijing

(1) Development Scale of Pharmaceutical Business in Beijing

(2) Market Structure of Pharmaceutical Business in Beijing

(3) Market Position of Pharmaceutical Business in Beijing

(4) Development Characteristics of Pharmaceutical Business in Beijing

(5) Delivery Solutions of Pharmaceutical Business in Beijing

(6) Competitive Structure of Pharmaceutical Business in Beijing

(7) Development Prospects of Pharmaceutical Business in Beijing

7.1.2 Analysis of Beijing Pharmaceutical Business Terminal

(1) Development Scale of Medical Institutions in Beijing

(2) Assets and Liability Scale of Medical Institutions in Beijing

(3) Revenue and Profit Scale of Medical Institutions in Beijing

(4) Status Changing of Medical Institutions in Beijing

(5) Per Capita Medicine Fee Scale of the Patients in Beijing

(6) Development of Retailing Drugstores in Beijing

7.2 Status and Terminal of Pharmaceutical Business in Shanghai

(the analysis items are identical to those of Beijing)

7.3 Status and Terminal of Pharmaceutical Business in Jiangsu


7.4 Status and Terminal of Pharmaceutical Business in Zhejiang


7.5 Status and Terminal of Pharmaceutical Business in Guangdong


7.6 Status and Terminal of Pharmaceutical Business in Shandong


7.7 Status and Terminal of Pharmaceutical Business in An’hui


7.8 Status and Terminal of Pharmaceutical Business in Tianjin


7.9 Status and Terminal of Pharmaceutical Business in Hubei


7.10 Status and Terminal of Pharmaceutical Business in Chongqing
